Based on the Oncomine database, we discovered that FKBP4 mRNA expression was significantly upregulated in cancerous samples compared with normal samples in more than nine types of cancer, including breast cancer, bladder cancer, colorectal cancer, gastric cancer, leukemia and so forth (Figure 1A). Here, FKBP4 is linked to urinary bladder cancer.